The Mechanism of Cytoplasmic Incompatibility

细胞质不相容的机制

基本信息

  • 批准号:
    10738499
  • 负责人:
  • 金额:
    $ 40.25万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-01-01 至 2024-12-31
  • 项目状态:
    已结题

项目摘要

Project Summary: Wolbachia are a genus of endosymbiotic bacteria that comprise a promising, cost-effective tool to curb Zika and dengue arboviral transmission based on two key facets. First, Wolbachia block pathogenic RNA viruses by inhibiting their replication in arthropods. Second, Wolbachia selfishly alter sperm and egg via a process termed cytoplasmic incompatibility (CI) that can drive the bacteria into host populations. CI is expressed as embryonic lethality in crosses between infected males and uninfected females, but this lethality is rescued in crosses between infected males and infected females, which are the transmitting sex of Wolbachia. Consequently, CI is deployed in field trials to either suppress mosquito population sizes or replace uninfected populations with infected individuals resistant to arboviral infection. We recently exposed a genetic model of CI wherein expression of two genes (cifA and cifB) causes embryonic lethality when expressed in testes, and expression of one of the same genes (cifA) rescues lethality when expressed in ovaries. Prior to embryonic lethality, several post-fertilization defects arise including delayed breakdown of the paternal nuclear envelope, mitotic arrest, and chromatin bridging. As Wolbachia are stripped from sperm during spermatogenesis, the defects caused by cifA and cifB may be due to uncharacterized pre-fertilization impairments to sperm integrity. Despite four decades of intense research and current applications to vector control efforts, the details surrounding these pre-fertilization impairments remain a central enigma. The overarching hypothesis of the proposed research is cifA and cifB encode proteins that alter sperm integrity to cause CI. In Aim 1, we will use cytochemical, enzymatic, and transgenic assays to determine the types, strength, and genetic bases of sperm modifications imposed by the Cif proteins from wMel Wolbachia released in field trials by the World Mosquito Program. In Aim 2, we will investigate localization patterns of the Cif proteins during spermatogenesis and storage. We will also identify important interactions between the Cif proteins and either host or Wolbachia proteins. Knockout and transgenic experiments will interrogate the necessity of the protein-protein interactions for expression of CI. Finally in Aim 3, we will evaluate if the natural CI proteins or protein complex can be experimentally isolated and successfully injected into uninfected hosts to recapitulate CI and rescue. In these experiments, we will evaluate a novel association between the Cif proteins and bacteriophage WO particles from Wolbachia. Studies have yet to yield a mechanistic breakthrough for the natural CI defects afflicting gametes, and the rising interest in deploying Wolbachia to curb arbovirus transmission necessitates an urgent understanding of the events underpinning the CI drive system. If successful, this research will fundamentally advance studies of CI modifications and inform Wolbachia's ongoing efficacy and delivery as a natural tool to control arthropods worldwide.
项目总结:

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SETH R BORDENSTEIN其他文献

SETH R BORDENSTEIN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SETH R BORDENSTEIN', 18)}}的其他基金

The Mechanism of Cytoplasmic Incompatibility
细胞质不相容的机制
  • 批准号:
    10078245
  • 财政年份:
    2020
  • 资助金额:
    $ 40.25万
  • 项目类别:
The Mechanism of Cytoplasmic Incompatibility
细胞质不相容的机制
  • 批准号:
    9885060
  • 财政年份:
    2020
  • 资助金额:
    $ 40.25万
  • 项目类别:
The Mechanism of Cytoplasmic Incompatibility
细胞质不相容的机制
  • 批准号:
    10322407
  • 财政年份:
    2020
  • 资助金额:
    $ 40.25万
  • 项目类别:
The Genetic Basis of Cytoplasmic Incompatibility
细胞质不相容的遗传基础
  • 批准号:
    9901416
  • 财政年份:
    2017
  • 资助金额:
    $ 40.25万
  • 项目类别:
The Genetic Basis of Cytoplasmic Incompatibility
细胞质不相容的遗传基础
  • 批准号:
    9366789
  • 财政年份:
    2017
  • 资助金额:
    $ 40.25万
  • 项目类别:
Molecular Evolution and Life Cycle of Wolbachia Bacteriophage
沃尔巴克氏菌噬菌体的分子进化和生命周期
  • 批准号:
    7848059
  • 财政年份:
    2008
  • 资助金额:
    $ 40.25万
  • 项目类别:
Molecular Evolution and Life Cycle of Wolbachia Bacteriohage
沃尔巴克氏菌噬菌体的分子进化和生命周期
  • 批准号:
    8098728
  • 财政年份:
    2008
  • 资助金额:
    $ 40.25万
  • 项目类别:
Molecular Evolution and Life Cycle of Wolbachia Bacteriohage
沃尔巴克氏菌噬菌体的分子进化和生命周期
  • 批准号:
    8288780
  • 财政年份:
    2008
  • 资助金额:
    $ 40.25万
  • 项目类别:
Molecular Evolution and Life Cycle of Wolbachia Bacteriohage
沃尔巴克氏菌噬菌体的分子进化和生命周期
  • 批准号:
    7506517
  • 财政年份:
    2008
  • 资助金额:
    $ 40.25万
  • 项目类别:
Molecular Evolution and Life Cycle of Wolbachia Bacteriohage
沃尔巴克氏菌噬菌体的分子进化和生命周期
  • 批准号:
    7676743
  • 财政年份:
    2008
  • 资助金额:
    $ 40.25万
  • 项目类别:

相似海外基金

University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
  • 批准号:
    10073243
  • 财政年份:
    2024
  • 资助金额:
    $ 40.25万
  • 项目类别:
    Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
  • 批准号:
    10752129
  • 财政年份:
    2024
  • 资助金额:
    $ 40.25万
  • 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
  • 批准号:
    2339201
  • 财政年份:
    2024
  • 资助金额:
    $ 40.25万
  • 项目类别:
    Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
  • 批准号:
    MR/Y008693/1
  • 财政年份:
    2024
  • 资助金额:
    $ 40.25万
  • 项目类别:
    Research Grant
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
  • 批准号:
    23K14783
  • 财政年份:
    2023
  • 资助金额:
    $ 40.25万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
  • 批准号:
    23KJ0394
  • 财政年份:
    2023
  • 资助金额:
    $ 40.25万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
  • 批准号:
    10076445
  • 财政年份:
    2023
  • 资助金额:
    $ 40.25万
  • 项目类别:
    Grant for R&D
PLA2G2D Antibodies for Cancer Immunotherapy
用于癌症免疫治疗的 PLA2G2D 抗体
  • 批准号:
    10699504
  • 财政年份:
    2023
  • 资助金额:
    $ 40.25万
  • 项目类别:
Genetic adjuvants to elicit neutralizing antibodies against HIV
基因佐剂可引发抗艾滋病毒中和抗体
  • 批准号:
    10491642
  • 财政年份:
    2023
  • 资助金额:
    $ 40.25万
  • 项目类别:
Novel Immunogens to Elicit Broadly Cross-reactive Antibodies That Target the Hemagglutinin Head Trimer Interface
新型免疫原可引发针对血凝素头三聚体界面的广泛交叉反应抗体
  • 批准号:
    10782567
  • 财政年份:
    2023
  • 资助金额:
    $ 40.25万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了